GLP-1 Medications Explained: Wegovy, Zepbound, Saxenda, and More

Introduction

GLP-1 medications have transformed obesity treatment.

For many patients, they are the first therapy that finally makes weight loss feel possible — not like a constant battle against hunger, cravings, and biology.

But most people don’t understand how these medications work, why they’re so effective, or how they differ from one another.

This article breaks down the science clearly and simply, so you understand exactly what GLP-1 medications do, who they help, and how they fit into long-term metabolic care.

1. What GLP-1 Medications Are — and Why They Matter

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after eating.

It signals:

• “I’m full.”
• “Slow down digestion.”
• “Lower blood sugar.”
• “Stop cravings.”

People with obesity often have blunted GLP-1 responses, meaning they don’t feel full as strongly or as quickly.

GLP-1 medications restore and amplify this natural signal.

What GLP-1 medications do:

• Reduce hunger
• Reduce cravings
• Slow gastric emptying
• Improve insulin sensitivity
• Lower blood sugar
• Reduce inflammation
• Support long-term weight loss

They treat obesity as the metabolic disease it is — not a willpower problem.

2. Wegovy (Semaglutide)

FDA-approved for:

• Chronic weight management
• Obesity
• Overweight with comorbidities

How it works:

• Strong GLP-1 activation
• Powerful appetite suppression
• Significant reduction in cravings
• Slower gastric emptying
• Improved insulin sensitivity

Expected weight loss:

• Substantial weight loss — among the largest seen with any weight-loss medication

Dosing:

• Weekly injection
• Gradual dose escalation

Who it’s best for:

• Patients needing strong appetite control
• Patients with emotional or binge eating
• Patients with insulin resistance or prediabetes

Wegovy is one of the most powerful nonsurgical weight-loss medications ever developed.

3. Zepbound (Tirzepatide)

FDA-approved for:

• Obesity
• Overweight with comorbidities

What makes it unique:

Zepbound activates two hormones:

• GLP-1
• GIP (glucose-dependent insulinotropic polypeptide)

This dual action creates a stronger metabolic effect.

Expected weight loss:

• The most weight loss of the medications discussed here
  Often approaching sleeve-level results.

How it works:

• Reduces hunger
• Reduces cravings
• Improves insulin sensitivity
• Enhances fat loss
• Improves metabolic markers

Who it’s best for:

• Patients with significant insulin resistance
• Patients with higher BMI
• Patients needing stronger metabolic improvement

Zepbound is currently the most powerful weight-loss medication available.

4. Saxenda (Liraglutide)

FDA-approved for:

• Chronic weight management

How it works:

• Daily GLP-1 injection
• Moderate appetite suppression
• Moderate metabolic effect

Expected weight loss:

• Modest weight loss — less than Wegovy or Zepbound

Who it’s best for:

• Patients who cannot tolerate stronger GLP-1s
• Patients needing a gentler option
• Patients wanting daily dosing

Saxenda is effective, but less powerful than Wegovy or Zepbound.

5. Ozempic vs. Wegovy — What’s the Difference?

Both contain semaglutide, but:

Ozempic

• FDA-approved for diabetes
• Lower maximum dose
• Weight loss is a secondary effect

Wegovy

• FDA-approved for obesity
• Higher maximum dose
• Designed specifically for weight loss

They are not interchangeable for insurance or medical purposes.

6. How GLP-1 Medications Actually Cause Weight Loss

1. They reduce hunger

Patients feel full sooner and stay full longer.

2. They reduce cravings

Especially for sugar and high-reward foods.

3. They slow gastric emptying

Food stays in the stomach longer, enhancing satiety.

4. They improve insulin sensitivity

Lower insulin levels → less fat storage.

5. They reduce inflammation

Improves metabolic health.

6. They lower the body’s defended weight (set point)

This is the key to long-term success.

These medications treat the biology of obesity — not the behavior.

7. Common Side Effects

Most side effects are gastrointestinal and improve over time:

• Nausea
• Bloating
• Fullness
• Constipation
• Diarrhea
• Fatigue

Slow dose escalation reduces symptoms significantly.

8. Who Should Not Take GLP-1 Medications

These medications are not appropriate for:

• Patients with personal/family history of medullary thyroid cancer
• Patients with MEN2 syndrome
• Patients with pancreatitis history (case-by-case)
• Patients with severe GI motility disorders

A medical evaluation is essential before starting therapy.

9. GLP-1 Medications vs. Bariatric Surgery

GLP-1s are powerful — but not as powerful as surgery for:

• Severe obesity
• Severe insulin resistance
• Severe metabolic disease
• Long-term durability

Best results often come from combining:

• Bariatric surgery
• GLP-1 therapy
• Nutrition
• Strength training
• Long-term follow-up

They are complementary tools, not competitors.

10. The Most Important Message: GLP-1s Are Real Medical Treatment

These medications are not:

• Cheating
• Shortcuts
• Easy ways out

They are evidence-based metabolic therapy for a chronic disease.

Patients who respond well often say:

• “This is the first time I’ve felt in control.”
• “Food doesn’t dominate my thoughts anymore.”
• “I finally understand what normal hunger feels like.”

That’s not psychology.

That’s physiology working correctly.

Conclusion

GLP-1 medications like Wegovy, Zepbound, and Saxenda are powerful tools that treat obesity at its biological root.

They:

• Reduce hunger
• Reduce cravings
• Improve insulin sensitivity
• Lower the set point
• Support long-term weight loss

For many patients, they are life-changing.

Understanding how they work — and how they differ — helps you choose the right tool for your biology, your goals, and your long-term health.